No phaseRecruitingGeroscience intervention
ICOPE INTENSE-K Pilot Study
A ICOPE Intense Program Combined With Ketone Ester Pilot Study
- Sponsor
- University Hospital, Toulouse (Academic or other)
- Enrollment
- 40 planned
- Conditions
- Ageing
- Interventions
- ICOPE intense intervention; Ketone Ester (KE) supplementation; Placebo; Vitamin D3; OMega 3; vitamin B9; Vitamin B12; Leucin-rich whey; ICOPE Step 1
- Ages
- older adults
- Registry
- NCT07048860
Full record on ClinicalTrials.gov
From the registry
ICOPE could constitute the reference model of care for healthy aging. More specifically, our hypothesis is that the intervention implemented in ICOPE may directly or indirectly prevent immuno-senescence, the loss of mobility and the cognitive decline. In future Geroscience clinical trials, ICOPE-Intense could become a benchmark to reduce the rate of aging with a strong non-pharmacological intervention and state a reference intervention to compare with new gerotherapeutic drugs.
Primary outcomes
- Estimation of the effect size of the intervention on the cognitive function
- Estimation of the effect size of the intervention on the muscle function
- Estimation of the effect size of the intervention on the immune function
History
Primary completion
Last registry update
Started
Registered